241 related articles for article (PubMed ID: 22258558)
1. A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.
Hirose M; Nishino T; Uramatsu T; Obata Y; Kitamura M; Kawazu T; Miyazaki M; Taguchi T; Kohno S
Clin Exp Nephrol; 2012 Jun; 16(3):473-9. PubMed ID: 22258558
[TBL] [Abstract][Full Text] [Related]
2. IgA nephropathy with minimal change disease.
Herlitz LC; Bomback AS; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1033-9. PubMed ID: 24721885
[TBL] [Abstract][Full Text] [Related]
3. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
Tsunehisa N; Takemura T; Inui T; Kamiya H
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
[TBL] [Abstract][Full Text] [Related]
4. Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?
Westhoff TH; Waldherr R; Loddenkemper C; Ries W; Zidek W; van der Giet M
Clin Nephrol; 2006 Mar; 65(3):203-7. PubMed ID: 16550751
[TBL] [Abstract][Full Text] [Related]
5. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
6. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
7. IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?
Brugnano R; Del Sordo R; Covarelli C; Gnappi E; Pasquali S
J Nephrol; 2016 Aug; 29(4):479-86. PubMed ID: 26842624
[TBL] [Abstract][Full Text] [Related]
8. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
McAdams AJ; Valentini RP; Welch TR
Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
[TBL] [Abstract][Full Text] [Related]
9. Electron microscopic findings suggestive of focal and segmental glomerulosclerosis in patients with steroid-resistant nephrotic syndrome.
Nili F; Saboori F; Jahanzad I; Mehrazma M
Ultrastruct Pathol; 2019; 43(1):6-12. PubMed ID: 30835594
[TBL] [Abstract][Full Text] [Related]
10. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
11. Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome.
Dong JH; Xu ST; Xu F; Zhou YC; Li Z; Li SJ
Clin Exp Nephrol; 2021 Mar; 25(3):270-278. PubMed ID: 33398597
[TBL] [Abstract][Full Text] [Related]
12. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
13. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
[TBL] [Abstract][Full Text] [Related]
14. Glomerulonephritis Histopathological Pattern Change.
AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
[TBL] [Abstract][Full Text] [Related]
15. Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: a separate entity? Observation of two cases.
Barbiano di Belgiojoso G; Mazzucco G; Casanova S; Radaelli L; Monga G; Minetti L
Am J Nephrol; 1986; 6(2):141-5. PubMed ID: 3518456
[TBL] [Abstract][Full Text] [Related]
16. Glomerulonephritis in Singapore: an overview.
Woo KT; Chiang GS; Edmondson RP; Wu AY; Lee EJ; Pwee HS; Lim CH
Ann Acad Med Singap; 1986 Jan; 15(1):20-31. PubMed ID: 3707031
[TBL] [Abstract][Full Text] [Related]
17. Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid-induced remission.
Cheng IK; Chan KW; Chan MK
Am J Kidney Dis; 1989 Nov; 14(5):361-4. PubMed ID: 2816928
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.
Kazi JI; Mubarak M; Ahmed E; Akhter F; Naqvi SA; Rizvi SA
Clin Exp Nephrol; 2009 Feb; 13(1):38-43. PubMed ID: 18685922
[TBL] [Abstract][Full Text] [Related]
19. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[TBL] [Abstract][Full Text] [Related]
20. [Influential factors for theraputic effect of steroid on adult primary nephrotic syndrome].
Chen C; Xia Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 40(1):78-82. PubMed ID: 25652378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
